InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Feltner Douglas E., Directeur Médical. Director active across 1 company, notably Exicure, INC.. Aggregated, 4 filings have been recorded. Activity tracked since 14 May 2021. The latest transaction was filed on 15 November 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
7,500 shares@ US$0.910.017% mcap21.5% of flowCommon StockSEC:0001209191-21-066474:0
7,500 shares@ US$0.9121.5% of flowCommon StockSEC:0001209191-21-066474
7,500 shares@ US$1.2728.5% of flowCommon StockSEC:0001209191-21-034586
7,500 shares@ US$1.270.023% mcap28.5% of flowCommon StockSEC:0001209191-21-034586:0
4 of 4 declarations
About Feltner Douglas E.
Douglas E. Feltner is Chief Medical Officer at Exicure, Inc., a biopharmaceutical company. In this role, he is responsible for the medical and scientific leadership of the company, overseeing the development of new treatments and therapies. Douglas brings significant expertise in the field of medicine and research.
